BCBS Michigan Highlights Medical, Benefit Policy Changes
February 12, 2024NGS to assess measurable residual disease
Additional payable diagnoses have been added, effective Nov. 1, 2023.
Payment policy: 0364U, 81479**
Payable diagnoses: C90.00, C90.01, C90.02, C91.00, C91.01, C91.02, C91.10, C91.11, C91.12, C91.30, C91.31, C91.32, C91.A0, C91.A1, C91.A2
Gene expression profiling for cutaneous melanoma
This policy was updated to cover procedure code *0089U when criteria are met, effective Sept. 1, 2023.
Source: https://www.bcbsm.com/content/dam/microsites/corpcomm/provider/the_record/2024/feb/Record_0224e.html